v3.25.2
Share-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-based Compensation Expense
The components of the Company’s share-based compensation expense for the six months ended June 30, 2025 and 2024 are as follows:
Six Months Ended June 30,
20252024
(in thousands)
Stock options$1,934 $353 
Restricted stock units and deferred stock units3,548 3,501 
Performance stock units713 665 
Employee Stock Purchase Plan84 78 
Total pre-tax share-based compensation expense charged against income$6,279 $4,597 
The following table summarizes the components of share-based compensation expense included within the Consolidated Statements of Comprehensive (Loss)/Income for the six months ended June 30, 2025 and 2024:

Six Months Ended June 30,
20252024
(in thousands)
Selling, general and administrative expense$6,257 $4,572 
Costs of services provided22 25 
Total share-based compensation expense$6,279 $4,597 
Schedule of Stock Options Outstanding
A summary of stock options outstanding under the Amended 2020 Plan and the 2012 Plan as of December 31, 2024 and changes during the six months ended June 30, 2025 are as follows:
Stock Options Outstanding
Number of SharesWeighted Average Exercise Price
(in thousands)
December 31, 20242,528 $28.23 
Granted269 $11.76 
Exercised— $— 
Forfeited— $— 
Expired(278)$31.22 
June 30, 20252,519 $26.14 
Schedule of Assumption for Fair Value of Options Granted
The fair value of stock option awards granted during the six months ended June 30, 2025 and 2024 was estimated on the dates of grant using the Black-Scholes option valuation model with the following assumptions:
Six Months Ended June 30,
20252024
Risk-free interest rate4.5 %3.9 %
Weighted average expected life7.2 years7.0 years
Expected volatility42.1 %40.5 %
Dividend yield— %— %
Schedule of Other Information about Stock Options
The following table summarizes other information about the stock options at June 30, 2025:
June 30, 2025
(amounts in thousands, except per share data)
Outstanding:
Aggregate intrinsic value$2,505 
Weighted average remaining contractual life5.0 years
Exercisable:
Number of options1,711 
Weighted average exercise price$32.05 
Aggregate intrinsic value$379 
Weighted average remaining contractual life3.6 years
Schedule of Outstanding Restricted Stock Units
A summary of the outstanding RSUs and DSUs as of December 31, 2024 and changes during the six months ended June 30, 2025 is as follows:
Restricted Stock Units & Deferred Stock Units
NumberWeighted Average Grant Date Fair Value
(in thousands)
December 31, 20241,516 $13.98 
Granted741 $11.89 
Vested(406)$16.19 
Forfeited(21)$12.36 
June 30, 20251,830 $12.66 
Schedule of Outstanding Performance Stock Units
A summary of the outstanding PSUs as of December 31, 2024 and changes during the six months ended June 30, 2025 is as follows:

Performance Stock Units
NumberWeighted Average Grant Date Fair Value
(in thousands)
December 31, 2024258 $15.31 
Granted106 $14.75 
Vested(31)$21.00 
Forfeited(29)$21.00 
June 30, 2025304 $14.00 
Schedule of Options Granted Under Employee Stock Purchase Plan
The expense associated with the options granted under the ESPP during the six months ended June 30, 2025 and 2024 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions:
Six Months Ended June 30,
20252024
Risk-free interest rate4.2%4.8%
Weighted average expected life (years)1.01.0
Expected volatility39.3%37.1%
Dividend yield—%—%
Schedule of Supplemental Employee Retirement Plan
The following table summarizes information about the SERP during the six months ended June 30, 2025 and 2024:
Six Months Ended June 30,
 20252024
(in thousands)
SERP expense1
$368 $355 
Unrealized gain recorded in SERP liability account$3,182 $5,350 
1.Both the SERP match and the deferrals are included in the Selling, general and administrative expense caption in the Consolidated Statements of Comprehensive (Loss)/Income.